|
1. Guo-Hua Yuan, Kayo Masuko-Hongo, Tomohiro Kato, and Kusuki
Nishioka. Immunologic Intervention in the Pathogenesis of
Osteoarthritis. Arthritis Rheum 48(3):602–611;2003.
2. Haq I,Murphy E , Dacre J. Osteoarthritis. Postgrad Med J 79
(933):377-383;2003.
3. Walker JM, Helewa A. Physical therapy in arthritis.
Philadelphia, PA:Saunders,1996.
4. Goldring SR, Gravallese EM. Mechanisms of bone loss in
inflammatory arthritis: diagnosis and therapeutic implications.
Arthritis Res 2(1):33-7;2000.
5.Robbins , J. R., B. Thomas , et al. Immortalized
human adult articular chondrocytes maintain cartilage-specific
phenotype and responses to interleukin-1beta. Arthritis Rheum 43
(10): 2189-201;2000.
6.Kojima T,Mwale F,Yasuda T,et al. Early degradation of type IX and
type II collagen with the onset of experimental inflammatory
arthritis. Arthritis Rheum 44(1):120-7;2001.
7.Sandell,L.J., and Aigner, T. Articular cartilage and
changes in arthritis. An introduction: cell biology of
osteoarthritis. Arthritis Res 3(2):107-113;2001.
8.Hideaki Nagase , J Frederick Woessner Jr . Matrix
Metalloproteinases. J.Biol.Chem 274(31):21491-494;1999
9.Dean DD , Martel-Pelletier J, Pelletier J-P, et al. Evidence for
metalloproteinase and metalloproteinase inhibitor imbalance in
human osteoarthritic cartilage. J Clin Invest 84:678–85;1989.
10.W W Bolten. Problem of the atherothrombotic potential of non-
steroidal anti-inflammatory drugs . Ann Rheum Dis
65:7-13;2006
11.Quilley J,McGiffJC. Eicosanoids. In Swales JD ,editor.
Textbook of hypertension. Oxford. Blackwell Scientific
Publications. 314-27;1994.
12. Kenta Matsuda,S Nakamura. Celecoxib inhibits nitric oxide
production in chondrocytes of ligament-damaged osteoarthritic
rat joints. Rheumatol Int. DOI 10.1007 /s00296-006-0107-6;2006.
13. AM. Panicoa,T , V. Cardileb, F. Garufia, et al. Protective
effect of Capparis spinosa on chondrocytes. Life
Sciences 77 :2479–2488;2005.
14. Chris to pher MB, Philip JF, Jennifer D, Rob ert AS, Rob
ert HM, Geoffrey B. Indomethacin potentiates the in
duc tion of HL60 differentiation to neutrophils, by retinoic
acid and granulocyte colony-stimulating factor, and to
Monocytes, by vitamin D3. Leukemia 8(4): 595-604;1994.
15. Venera Cardile. Effect of propolis on human cartilage and
chondrocytes. Life Sciences 73 :1027–1035;2003.
16. Khasigov, P. Z., O. V. Podobed , et al. Role of
matrix metalloproteinases and their inhibitors
in tumor invasion and metastasis. Biochemistry
(Mosc) 68(7): 711-7;2003.
17. Woessner, J. F. Matrix metalloproteinases and their
inhibitors in connective tissue remodeling.FASEB J. 5(8): 2145-
2154;1991.
18. Tokumaru Y., Fujii M., Otani Y., Kaneyama K.,
Imanishi, Y., Igarashi, N., and Kanzaki, J.
Cancer Lett 150:15-21;2000.
19. Matrisian, L. M. The matrix - degrading
metalloproteinases.BioEssays 14(7): 455-463;1992.
20. Quantin B. , Murphy G. , and Breathnach R.
Biochemistry 28: 5327-5334;1989.
21. Von Bredow D. C. , Nagle R. B. , Bowden G. T., and
Cress, A. E. Degradation of fibronectin fibrils by matrilysin and
characterization of the degradation products. Exp. Cell Res. 221
(1):83-91;1995.
22. Uria J. A., Stahle_Backdahl M., Seiki M., Fueyo A.et al
Regulation of collagenase-3 expression in human breast carcinomas
is mediated by stromal-epithelial cell interactions. Cancer Res 57
(21): 4882-4888;1997.
23. Pei, D., and Weiss, S. J. Transmembrane-deletion mutants
of the membrane - type matrix metalloproteinase- 1
process progelatinase A and express intrinsic
matrix-degrading activity.J. Biol. Chem 271(15):
9135-9140;1996.
24. Goetzl, E.J. Specificity of expression and effects of
eicosanoid mediators in normal physiology and human
diseases. FASEB J.9: 1051–1058;1995.
25. Smith, W.L. Pharmacology of prostaglandin endoperoxide
synthase isozymes 1 and 2. Ann. New York Acad. Sci.
714;1994.
26. Poole AR, Rizkalla G, Ionescu M, Reiner A, Brooks E,
Rorabeck C, et al. Osteoarthritis in the human knee:
a dynamic process of cartilage matrix degradation,
synthesis and reorganization. Agents Actions
39(Suppl):3–13;1993.
27. Paulsson M , Morgelin M , Wiedemann H , et al. Extended
and globular protein domains in cartilage proteoglycans. Biochem
J 245(3):763-72;1987.
28. J. D. Sandy Ph.D. A contentious issue .nds some clarity:
on the independent and complementary roles of
aggrecanase activity and MMP activity in human joint
aggrecanolysis .OsteoArthritis and Cartilage 14(2):
95-100;2006.
29. David Eyre . Collagen of articular cartilage.
Arthritis Res 4:30-35;2002.
30. Darko Bosnakovski , Morimichi Mizuno , Gonhyung Kim ,
Et al. Chondrogenic Differentiation of Bovine Bone
Marrow Mesenchymal Stem Cells (MSCs) in Different
Hydrogels : Influence of Collagen Type II
Extracellular Matrix on MSC Chondrogenesis. Wiley InterScience
9,DOI: 10.1002/bit.20828;2006.
31.Hughes R , Carr A . A randomized , double-blind ,
placebo-controlled trial of glucosamine sulphate as
an analgesic in osteoarthritis of the knee.
Rheumatology 41(3):279–84;2002.
32.Oegema TR Jr, Deloria LB, Sandy JD, Hart DA. Effect of oral
glucosamine on cartilage and meniscus in normal and
chymopapaininjected knees of young rabbits. Arthritis Rheum 46
(9): 2495–503;2002.
33. Hua J, Sakamoto K, Nagaoka I. Inhibitory actions of
glucosamine,a therapeutic agent for osteoarthritis, on the
functions of neutrophils.J Leukoc Biol 71: 632–40;2002.
34. Muller-Fassbender H, Bach G , Haase W, Rovati AL:
Glucosamine sulfate compared to ibuprofen in
osteoarthritis of the knee. Osteoarthritis Cart
2:51–59;1994.
35. Karzel K , Domenjoz R : Effects of hexosamine
derivatives and uronic acid derivatives on glycosaminoglycan
metabolism of fibroblast cultures.
Pharmacology 5:337–45;1971.
36. G. R. Dodge Ph.D. *, S. A. Jimenez M.D. Glucosamine sulfate
modulates the levels of aggrecan and matrix metalloproteinase- 3
synthesized by cultured human osteoarthritis articular
chondrocytes. OsteoArthritis and Cartilage 11(6): 424–432;2003.
37. Zhiyong Fan, Brigitte Bau, Huiqing Yang, Stephan Soeder, and
Thomas Aigner. Freshly Isolated Osteoarthritic Chondrocytes Are
Catabolically More Active Than Normal Chondrocytes, but Less
Responsive to Catabolic Stimulation With Interleukin-1β.
Arthritis Rheum 52(1) : 136–143;2005.
38. Chevalier X . Upregulation of enzymatic activity by
interleukin-1 in osteoarthritis.Biomed Pharmacother 51(2):58–
62;1997.
39. M. J. Lo’pez-Armada Ph.D., B. Carame’s Ph.D., M. Lires-
Dea’n B.S. Cytokines, tumor necrosis factor-a and interleukin-
1b, differentially regulate apoptosis in osteoarthritis cultured
human chondrocytes. OsteoArthritis and Cartilage.
doi:10.1016/j.joca.;2006.
40. Stephen Marshall , Owen Nadeau, Kazumitsu Yamasaki .
Glucosamine - induced Activation of Glycogen
Biosynthesis in Isolated Adipocytes . J.Biol.chem
280(12) : 11018–11024;2005.
41. Dong-Ho Han, M M Chen. Glucosamine and glucose induce
insulin resistance by different mechanisms in rat
skeletal muscle.Am J Physiol Endocrinol Metab 285(6):
E1267–E1272; 2003.
42. T. Sadowski and J. Steinmeyer. Effects of non-steroidal
antiinflammatory drugs and dexamethasone on the activity and
expression of matrix metalloproteinase-1, matrix metalloproteinase- 3 and tissue inhibitor of metalloproteinases-1 by bovine
articular chondrocytes. Osteoarthritis and Cartilage. 9(5): 407–
415;2001.
43. R. Largo ,MA Alvarez-Soria. Glucosamine inhibits IL-1β-induced
NFκB activation in human osteoarthritic chondrocytes.
OsteoArthritis and Cartilage 11(4): 290–298;2003.
44. Theodorep, Ciaraldi, Leslie et al. Glucosamine Regulation of
Glucose Metabolism in Cultured Human Skeletal Muscle Cells:
Divergent Effects on GlucoseTransport/Phosphorylation and
Glycogen Synthase in Non-Diabetic and Type 2 Diabetic
Subjects.Endocrinology 140: 3971–3980; 1999.
|